Taiwan Academy of Tumor Ablation (TATA) consensus
on hepatocellular carcinoma ablation

The guideline described herein, initiated
by the Taiwan Academy of Tumor Ablation, was developed through collaboration among hepatology, surgery, radiology, and
oncology experts. The process followed principles of evidence-based medicine and employed the Delphi method to reach
consensus. In phase one, a systematic literature review and expert surveys informed preliminary recommendations, which
were refined through online discussions. In phase two, structured voting with statistical analysis was performed to assess
the consistency and strength of agreement. The final guideline provides detailed, evidence-based recommendations with
explanatory notes. It incorporates emerging technologies, reflects recent clinical advances, and anticipates future trends,
including the integration of artificial intelligence and automation into HCC ablation therapy.